CSE Bulletin: Suspensions - ADMT, ABRT, CFT, GAIA, IWIN, PKG, POLE, PRTI, RWB, CALM, RVR, VEJI Pharmaceutical Investing
Knight to Present at the 2023 RBC Capital Markets Global Healthcare Conference in New York City Pharmaceutical Investing
Gilead Strengthens Early Pipeline in Oncology and Inflammation Through the Acquisition of XinThera Life Science Investing News
Health Canada Approves AbbVie's RINVOQ® for the Treatment of Adults with Active Non-Radiographic Axial Spondyloarthritis Life Science Investing News
Aurinia Pharmaceuticals Announces Kidney Biopsies Sub-study Data from the LUPKYNIS® AURORA 2 Clinical Trial Presented at Congress of Clinical Rheumatology East Conference Pharmaceutical Investing
Salix Pharmaceuticals to Deliver Podium Presentation at Digestive Disease Week 2023 Pharmaceutical Investing
Arvinas and Pfizer Announce Upcoming Vepdegestrant Poster Presentations at the 2023 European Society for Medical Oncology Breast Cancer Annual Congress Life Science Investing News
AbbVie Releases New Data Demonstrating Breadth of Its Gastroenterology Portfolio at 2023 Digestive Disease Week® Pharmaceutical Investing
Jamieson Wellness Inc. Reports First Quarter 2023 Results, Maintains Full Year Outlook and Declares First Quarter Dividend Life Science Investing News
Jamieson Wellness Inc. Completes Previously Announced Distributor Transaction in China Life Science Investing News
